Ombay, Bonita F.

HRN: 04-84-43  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2025
CEFUROXIME 1.5GM (VIAL)
03/25/2025
03/26/2025
IV
1.5 Gms
Now
STAT CS
Waiting Final Action 
03/25/2025
CLINDAMYCIN 300MG (CAP)
03/25/2025
03/26/2025
IV
900mg
Q8h X3 Doses
SP RLTCS W/ BTL
Waiting Final Action 
03/25/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
03/25/2025
03/25/2025
IV
240mg
1 Dose
SP RLTCS W BTL
Waiting Final Action 
03/25/2025
CEFUROXIME 500MG (TAB)
03/25/2025
04/01/2025
ORAL
1 Tab
BID
SP RLTCS W BTL
Waiting Final Action 
03/25/2025
MUPIROCIN 2%, 15G (TUBE)
03/25/2025
04/01/2025
TOPICAL
2%
BID
SP RLTCS W BTL
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: